BPA calls for yellow fever and polio vaccines - october 2016

Ended Awarded Last action

Contract number
1016
Awardee
Awarding agency
Obligated
$31,844

Award facts

Contract value 1% obligated
  • $31,844.00 Current, with exercised options
  • $2,500,000.00 Potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Germany

Award details come from SAM.gov/FPDS.

About this award

This is a Blanket Purchase Agreement (BPA) call issued by the Medical Command of the U.S. Department of Defense for the procurement of yellow fever and polio vaccines in October 2016. The contract was awarded to Sanofi Pasteur Inc., a major pharmaceutical manufacturer, on a firm fixed-price basis without any set-aside designation. The contract had a ceiling value of $2,500,000.00 and a completion date of October 31, 2016. Sanofi Pasteur Inc. has a strong track record of providing a wide range of vaccines and pharmaceutical products to various U.S. government agencies through multiple Indefinite Delivery Vehicles (IDVs), including a $5.87 billion IDIQ contract with the HHS Office of the Assistant Secretary for Preparedness and Response, as well as several BPA and FSS contracts with the CDC, DLA, and other federal entities. The award of this BPA call to Sanofi Pasteur Inc. leverages the company's manufacturing capabilities and distribution infrastructure to fulfill the DoD's requirement for yellow fever and polio vaccines in a timely and efficient manner.

Quick answers

Who was awarded contract 1016?

1016 was awarded to Sanofi Vaccines US Inc. by Medical Command (Department of the Army) on October 1, 2016.

How much is contract 1016 worth?

The government has obligated $31,844 on 1016. Its potential value, with all options, is $2,500,000.

Is contract 1016 an order under another contract?

Yes. 1016 is a BPA call under V797D50457-W9114F16A0009, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 1016 competed?

The extent of competition for 1016 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award